Tumani H - Search Results

1

[Current cerebrospinal fluid diagnostics for pathogen-related diseases].

Süssmuth SD, Brettschneider J, Spreer A, Wick M, Jesse S, Lewerenz J, Otto M, Tumani H. Süssmuth SD, et al. Among authors: tumani h. Nervenarzt. 2013 Feb;84(2):229-44. doi: 10.1007/s00115-012-3701-8. Nervenarzt. 2013. PMID: 23371378 Free PMC article. Review. German.

2

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S. Otto M, et al. Among authors: tumani h. Neurosci Lett. 1997 Apr 11;225(3):210-2. doi: 10.1016/s0304-3940(97)00215-2. Neurosci Lett. 1997. PMID: 9147407

3

Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases.

Süssmuth SD, Reiber H, Tumani H. Süssmuth SD, et al. Among authors: tumani h. Neurosci Lett. 2001 Mar 9;300(2):95-8. doi: 10.1016/s0304-3940(01)01556-7. Neurosci Lett. 2001. PMID: 11207383

4

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b.

Brettschneider J, Ecker D, Bitsch A, Bahner D, Bogumil T, Dressel A, Elitok E, Kitze B, Poser S, Weber F, Tumani H. Brettschneider J, et al. Among authors: tumani h. J Neuroimmunol. 2002 Dec;133(1-2):193-7. doi: 10.1016/s0165-5728(02)00353-3. J Neuroimmunol. 2002. PMID: 12446022

5

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum.

Süssmuth SD, Tumani H, Ecker D, Ludolph AC. Süssmuth SD, et al. Among authors: tumani h. Neurosci Lett. 2003 Dec 15;353(1):57-60. doi: 10.1016/j.neulet.2003.09.018. Neurosci Lett. 2003. PMID: 14642437

6

Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus?

Brettschneider J, Riepe MW, Petereit HF, Ludolph AC, Tumani H. Brettschneider J, et al. Among authors: tumani h. J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1614-6. doi: 10.1136/jnnp.2003.026013. J Neurol Neurosurg Psychiatry. 2004. PMID: 15489398 Free PMC article.

7

The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

Kaufmann E, Boehm BO, Süssmuth SD, Kientsch-Engel R, Sperfeld A, Ludolph AC, Tumani H. Kaufmann E, et al. Among authors: tumani h. Neurosci Lett. 2004 Nov 23;371(2-3):226-9. doi: 10.1016/j.neulet.2004.08.071. Neurosci Lett. 2004. PMID: 15519762

8

Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases.

Brettschneider J, Claus A, Kassubek J, Tumani H. Brettschneider J, et al. Among authors: tumani h. J Neurol. 2005 Sep;252(9):1067-73. doi: 10.1007/s00415-005-0817-9. Epub 2005 Apr 1. J Neurol. 2005. PMID: 15789126

9

Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.

Uttner I, Müller S, Zinser C, Maier M, Süssmuth S, Claus A, Ostermann B, Elitok E, Ecker D, Brettschneider J, Gold R, Tumani H. Uttner I, et al. Among authors: tumani h. Neurology. 2005 Jun 14;64(11):1971-3. doi: 10.1212/01.WNL.0000163804.94163.91. Neurology. 2005. PMID: 15955958 Clinical Trial.

10

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

Brettschneider J, Maier M, Arda S, Claus A, Süssmuth SD, Kassubek J, Tumani H. Brettschneider J, et al. Among authors: tumani h. Mult Scler. 2005 Jun;11(3):261-5. doi: 10.1191/1352458505ms1159oa. Mult Scler. 2005. PMID: 15957504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters